Mental retardation : developing pharmacotherapies

Bibliographic Information

Mental retardation : developing pharmacotherapies

edited by John J. Ratey

(The Progress in psychiatry series / David Spiegel, series editor, no. 32)

American Psychiatric Press, c1991

Available at  / 3 libraries

Search this Book/Journal

Note

Includes bibliographical references

Includes index

Description and Table of Contents

Description

In the last few years, psychiatry in the field of mental retardation has begun to reexamine the subtler effects of the medications it employs. This volume is designed to further our understanding of the pharmacologic treatability of the mental illnesses that individuals with mental retardation often display. The book shows how mentally retarded patients can benefit from pharmacological interventions that are part of a multisystems approach to treatment, the aim of which is to maintain or increase the cognitive functioning of the individual. In this respect, pharmacologic and polypharmacologic approaches are sought to provide more efficacious, less toxic treatment regimens for these patients. New insights into the nature of neurological disturbance in mental retardation are presented, and the book offers a practical guide to the treatment of developmentally disabled people.

Table of Contents

Neuropsychiatry and mental retardation. Mental illness in the mentally retarded: diagnostic clarity as a prelude to psychopharmacological interventions. TMS: a system for prevention and control. ?-blockers as primary treatment for aggression and self-injury in the developmentally disabled. Use of anticonvulsant agents for treatment of neuropsychiatric disorders in the developmentally disabled. Effects of opioid receptor antagonists in treatment of autism and self-injurious behavior. Amantadine: profile of use in the developmentally disabled.

by "Nielsen BookData"

Related Books: 1-1 of 1

Details

Page Top

AltStyle によって変換されたページ (->オリジナル) /